August 2015 Issue of The Ophthalmologist

But he still doesn’t have a “bionic eye”, no matter what the newspapers tell you.

The story behind the headlines heralding eyedrops that can “dissolve cataracts”

The Argus II: Thirty Patients with RP, Three Years Later

An updated surgical technique restores sensation to patients with corneal anesthesia

Unicellular planktonic organisms have evolved a complex eye-like structure by repurposing organelles within the cell

Stem cell therapies may be the future of treating retinal disease, but how do you choose the best source?

“Smart” nanowires deliver drugs on demand using an applied electromagnetic field

The long and controversial journey to microinvasive glaucoma surgery (MIGS), and the quest to retire trabeculectomy

When considering patients’ functional vision needs and satisfaction levels, intermediate vision has been overlooked for too long – new trifocal mIOLs may change that

We interviewed a patient who had undergone refractive lens exchange about her motivation to undergo her surgery, and how she feels about her post-surgical vision. Here is the transcript of that interview.

Monofocal IOLs allow patients to retain good near and distance vision, typically with high levels of satisfaction. So why isn’t monovision more popular with surgeons?

A new ocular biometer automates IOL selection and offers an exciting alternative to sometimes unpredictable IOL power formulae

Can the combination of 360° haptics and a novel protective membrane, which emulates the pattern found on shark skin, in a single IOL prevent PCO and make YAG laser capsulotomies a thing of the past?

The rise of the experience economy means that ophthalmology practices must go to great lengths to ensure their patients are receiving not just the best medical care, but also the best possible customer service

Using social media platforms to interact, educate and promote your practice

Sitting Down With… Joan Miller, Chief and Chair of the Department of Ophthalmology, Massachusetts Eye and Ear, Mass General Hospital and Harvard Medical School

Taking the time to talk with patients about the signs and symptoms of ocular surface disease and performing some quick assessments could ensure selection of the most appropriate therapy, and help improve patient outcomes

We spoke with three eminent refractive cataract surgeons about their experience with LENSAR with Streamline

Five Things We Learned This Month